|
|
|
|
|
by trott
614 days ago
|
|
You originally wrote: > very, very, few drugs are "novel" as opposed to being analogues of something naturally in the body But "analog" means "structural analog" in this context (see https://en.wikipedia.org/wiki/Structural_analog ), which is why people disagreed with you, presumably. It appears that you were merely saying that ligands must adopt a 3D conformation that's complementary to the receptor. Sure. That's the entire premise of molecular docking software. But there can be very dissimilar ligands (like morphine and fentanyl) binding the same receptors. A major goal of drug discovery is to find such novel binders, not to regurgitate known ones. |
|